Literature DB >> 74535

Miconazole-resistant Candida.

R J Holt, A Azmi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 74535     DOI： 10.1016/s0140-6736(78)90403-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.

Authors:  R Pelletier; J Peter; C Antin; C Gonzalez; L Wood; T J Walsh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Clinical isolates of Canada albicans.

Authors:  R J Holt
Journal:  Infection       Date:  1979       Impact factor: 3.553

3.  In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus.

Authors:  H C Korting; M Ollert; A Georgii; M Fröschl
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

Review 4.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

5.  Evaluation of five commercial antifungal susceptibility testing systems.

Authors:  A Druetta; A Freydiere; R Guinet; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

6.  Evaluating diagnosis and treatment of oral and esophageal candidiasis in Ugandan AIDS patients.

Authors:  M Ravera; A Reggiori; A M Agliata; R P Rocco
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

7.  Fluconazole resistance in Candida glabrata.

Authors:  C A Hitchcock; G W Pye; P F Troke; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.

Authors:  F Barchiesi; A L Colombo; D A McGough; A W Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

Review 9.  Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections.

Authors:  R C Heel; R N Brogden; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

10.  Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing.

Authors:  R Guinet; D Nerson; F de Closets; J Dupouy-Camet; L Kures; M Marjollet; J L Poirot; A Ros; J Texier-Maugein; P J Volle
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.